News

Hims & Hers Receives Price Target Boost from Bank of America

Hims & Hers Receives Price Target Boost from Bank of America

Bank of America Raises Price Target for Hims & Hers

Bank of America has recently raised its price target for Hims & Hers Health. The new price target is set at $25, up from the previous $23. This adjustment comes as a result of strong core sales trends that suggest there is potential for upside in the company’s upcoming third-quarter revenue.

Optimistic Outlook Amid Deceleration in Growth

Despite witnessing some deceleration in growth during September, analysts from Bank of America maintain a positive outlook on the company's growth trajectory. They have reiterated a Buy rating, indicating confidence in Hims & Hers' future performance.

Sales Growth Trends

According to analysts, Hims observed a year-over-year sales growth decline as indicated by recent Bloomberg Second Measure credit and debit card data. This deceleration occurred after five consecutive months of sales acceleration.

Forecasting Revenue Estimates

Even with the noted slowdown in sales, Bank of America points out that the data suggests a potential upside of 5-8% to the Virginia consensus revenue estimates for the upcoming quarter. This projection takes into account deferred GLP-1 sales, which are crucial for the company.

Impact of GLP-1 Medications

Bank of America highlights the significance of GLP-1 medications—widely recognized for their use in weight loss and diabetes treatment—in Hims & Hers' revenue streams. For the third quarter, these medications are expected to generate revenue between $76 million and $81 million. However, it is important to note that a portion of this revenue, estimated to be between 10% and 20%, is likely to be deferred due to longer-duration subscriptions.

Revenue Projections

This deferral may create a headwind of approximately $8 million to $16 million for the quarter. Consequently, the anticipated revenue range for Q3 is projected to be between $398.5 million and $406.5 million, which is significantly higher than Wall Street's previous forecast of $382.3 million.

Core Operations and Digital Engagement

According to Bank of America, there are encouraging signs regarding Hims & Hers' core operations. The analysts stated that the core growth remains stable and is showing signs of acceleration, which suggests resilience beyond the contributions from GLP-1 medications.

Navigating Competition

It is crucial to consider the competitive landscape, particularly in the weight loss space. The analysts cautioned that if the contributions from GLP-1 medications begin to slow, it could potentially impact future quarters negatively.

Digital Engagement Metrics

In terms of digital engagement, analysts reported a notable 21.9% year-over-year increase in web visits as of September, which marks the third consecutive month of increasing traffic. However, there was some concern as app downloads experienced a decline for the first time in a year, signaling possible changes in user behavior.

Increased Valuation Multiple

Reflecting the strong core trends observed in the business, Bank of America has raised Hims & Hers' valuation multiple from 25x to 27x for the calendar year 2025's EBITDA. This adjustment underscores the bank's confidence in the company's ability to continue on its upward trajectory, emphasizing the factors and trends that contribute to its long-term success.

Frequently Asked Questions

What is the new price target for Hims & Hers set by Bank of America?

The new price target is $25, raised from $23, based on positive sales trends.

How has Hims & Hers’ sales growth changed recently?

Sales growth has decelerated in September after five months of acceleration, according to Bloomberg data.

What impact do GLP-1 medications have on Hims & Hers?

GLP-1 medications are projected to contribute between $76 million and $81 million in Q3 but may face deferred revenue challenges.

How is digital engagement performing for Hims & Hers?

Web visits increased by 21.9% year-over-year in September, but app downloads have declined for the first time in a year.

What is the updated valuation multiple for Hims & Hers?

Bank of America raised the valuation multiple to 27x for CY25 EBITDA, reflecting strong core growth trends.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

IP Lawyer Chris Henry Returns to Latham: A Game Changer

Updated Category News Views 138

Welcome Home, Chris Henry! Folks, here's a headline that's making waves in the IP litigation water: Chris Henry has returned to Latham & Watkins, taking his place as a heavyweight partner in their Boston office. Now, if you're not deeply entangled in the world of high-stakes intellectual property (IP) disputes, you might shrug. But for tech companies embroiled in patent...

Continue Reading
Intel Faces Class Action Over Alleged Securities Fraud

Updated Category News Views 84

Intel's Legal Predicament: Decoding the Lawsuit Saddle up, folks, because Intel (NASDAQ: INTC) has found itself tangled in legal vines again. This ain't their first rodeo, and probably won't be their last. We're looking at a hefty class action lawsuit rallying on claims that Intel misled investors with optimistic yarns about their health. SBS Law, waving the litigation...

Continue Reading
Silvi's Expansion Push: New Terminal in Wilmington

Updated Category News Views 113

Silvi's Latest Bet on the Southeast You know, sometimes you get a gut feeling that a company is rolling out chess moves instead of checkers. That’s what Silvi Materials is up to with their new project in Wilmington. It’s not just some fancy cement terminal—it’s a calculated expansion into the heart of the Southeast construction market. The Port of Wilmington’s...

Continue Reading
Visit W&H at the Greater New York Dental Meeting

Updated Category News Views 89

Why This Event Matters for Dental Professionals Stroll through any convention center halls and you can see the future unfolding right in front of you. The upcoming Greater New York Dental Meeting is no different, especially with W&H Group setting up shop. For any dental professionals out there, this is your chance to get your hands on some real-deal tech that might just...

Continue Reading
AvidXchange Acquisition Faces Fairness Investigation

Updated Category News Views 100

Unpacking the AvidXchange Turmoil Staring at the ticker tape feels like watching a drama unfold, and today it's all about AvidXchange Holdings, Inc. (NASDAQ: AVDX). Levi & Korsinsky, LLP has launched an investigation into the fairness of its acquisition, and let me tell you, when the suits start poking around, it means someone smells a rat. The deal in question? A buyout...

Continue Reading
Portillo's Faces Legal Heat: Investor Class Action Filed

Updated Category News Views 162

What’s Eating Portillo's? Ah, once upon a misstep in the land of promising expansion, now we have Portillo's Inc. (NASDAQ: PTLO) neck-deep in legal hot water. Those golden fries and famous sandwiches somehow didn't pave the way for stockholder bliss. Why the turmoil? On an ordinary November morning, the DJS Law Group made it clear: They're rallying the troops for a...

Continue Reading
Greenberg Traurig Cheers Clients' 69th GRAMMY® Nods

Updated Category News Views 49

A Momentous Occasion for Greenberg Traurig's Entertainment Clients Oh, the glamour and glitz of the music world! There's nothing quite like the GRAMMY® Awards to stir up a blend of excitement, ego, and anxiety in the industry. This time around, the lawyers over at Greenberg Traurig are beaming with pride as their clients scoop up nominations for the 69th Annual GRAMMY®...

Continue Reading
Christian Faith: Navigating Spiritual Pitfalls Wisely

Updated Category News Views 195

Taking a Deep Look at Christian Faith If you think faith is as simple as saying a few prayers and checking church attendance off the list, well, think again. G. Joseph Johnson, in his thought-provoking tome "Roads, Ditches, Traps, and Snares," believes that faith is a journey filled with twists, turns, and yes, a few traps. This book is a sort of roadmap for Christians,...

Continue Reading
Palatin's Game-Changer: MC4R Agonist Hits the Stage

Updated Category News Views 103

Breaking New Ground in Obesity Treatment Palatin Technologies is stepping into the spotlight with some heavy ammunition in the fight against obesity. The company has just unveiled impressive preclinical data about their next-generation melanocortin-4 receptor (MC4R) agonists at the ObesityWeek® 2026 conference. This isn’t just your run-of-the-mill corporate...

Continue Reading
SKE Capitalizes on Halloween Events in London

Updated Category News Views 104

SKE's Bold Step into London's Halloween Vibe Hah! Who would've thought that vaping and Halloween could be a match made in heaven? This year, SKE threw its hat into the ring and wrestled for attention in London’s bustling Halloween music scene. Imagine an entire warehouse pulsing not just with beat-heavy electronic music, but the energy of vaping enthusiasts courtesy of...

Continue Reading

Top 5 Most Recently Viewed Articles

Why Investors Are Making Bold Moves with Dell Technologies

Updated Category News Views 178

Investors Show Confidence in Dell Technologies In recent trading sessions, significant investors have adopted a bullish approach to Dell Technologies (NYSE: DELL). Such movements usually signal investor confidence and the possibility of future price movements. Interestingly, options trading data we've analyzed indicates that this activity stemmed from large transactions,...

Continue Reading
Community Heritage Financial Strengthens Capital Position with Debt Offering

Updated Category News Views 78

Community Heritage Financial Completes Subordinated Debt Offering Community Heritage Financial, Inc. (OTC PK: CMHF), parent company of Middletown Valley Bank, has successfully executed a private placement of subordinated debt, amounting to a substantial $12.1 million. This offering of 6.75% Fixed-to-Floating Rate Subordinated Notes, due 2034, reflects the Company’s...

Continue Reading
Evolent Health Poised for Growth Amid Humana Challenges

Updated Category News Views 185

Understanding Evolent Health's Market Position Recently, analysts at Barclays have reaffirmed their positive outlook on Evolent Health (NYSE: EVH), maintaining an Overweight rating and a price target of $39.00. This confidence comes in light of discussions surrounding the impacts of Humana's recent struggles with Medicare Star ratings. The management team at Evolent,...

Continue Reading
Caracole Teams with Centric PLM for Seamless Growth

Updated Category News Views 31

Revolutionizing the Luxury Furniture Game In the world of luxury furnishings, where every curve and finish sends a message, Caracole is making a bold move to streamline its operations. They're throwing the confetti for Centric PLM, a platform that's set to oust the scattered chaos of spreadsheets and emails. And let me tell you, for any investor eyeing the luxury home...

Continue Reading
RaySearch Laboratories: Exciting Year-End Presentation Ahead

Updated Category News Views 105

Join Us for RaySearch Laboratories' Year-End Report Presentation Analysts, investors, and media representatives are cordially invited to a detailed presentation focused on RaySearch Laboratories' Year-end report for the year 2024. Details of the Presentation Set for February 21, 2025, at 10:00 AM CET, the report will be made accessible to attendees starting at 07:45 AM on...

Continue Reading